Clinical Trial Update: Thymoquinone as an add-on Therapy for the Management of Patients With Diabetic Peripheral Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated thymoquinone as add-on therapy for diabetic peripheral neuropathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Thymoquinone (thymoquinone)

Snippet

Sponsor: Hawler Medical University | Conditions: Diabetic Peripheral Neuropathy (DPN) | Phase 4 | Status: COMPLETED